Relief Therapeutics Holding SA Stock price
Equities
RLF
CH1251125998
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 CHF | -2.26% | -0.76% | -34.67% |
Mar. 22 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Mar. 22 | Sector Update: Health Care | MT |
Sales 2021 | 3.32 2.99 | Sales 2022 | 6.08 5.48 | Capitalization | 132M 119M |
---|---|---|---|---|---|
Net income 2021 | -34M -30.65M | Net income 2022 | -50M -45.07M | EV / Sales 2021 | 70,411,981 x |
Net cash position 2021 | 40.5M 36.5M | Net cash position 2022 | 14.89M 13.42M | EV / Sales 2022 | 19,251,190 x |
P/E ratio 2021 |
-6.44
x | P/E ratio 2022 |
-2.5
x | Employees | 69 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.87% |
1 day | -2.26% | ||
1 week | -0.76% | ||
Current month | -14.47% | ||
1 month | -17.83% | ||
3 months | -29.73% | ||
6 months | -40.91% | ||
Current year | -34.67% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Thomas Plitz
BRD | Director/Board Member | 56 | 20-12-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.3 | -2.26% | 23,838 |
24-03-27 | 1.33 | -3.62% | 23,029 |
24-03-26 | 1.38 | -2.82% | 11,941 |
24-03-25 | 1.42 | 0.00% | 15,775 |
24-03-22 | 1.42 | +8.40% | 42,656 |
End-of-day quote Swiss Exchange, March 27, 2024
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.67% | 18.1M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |